BRAIN Stock Overview
A medical device company, together with its subsidiaries, engages in the development, marketing, and sale of medical cooling systems for the healthcare sector in Sweden. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
BrainCool AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | SEK 1.58 |
| 52 Week High | SEK 5.88 |
| 52 Week Low | SEK 1.21 |
| Beta | 1.65 |
| 11 Month Change | -17.12% |
| 3 Month Change | -24.50% |
| 1 Year Change | -68.44% |
| 33 Year Change | -77.77% |
| 5 Year Change | -70.67% |
| Change since IPO | -49.75% |
Recent News & Updates
Recent updates
Is BrainCool (NGM:BRAIN) In A Good Position To Invest In Growth?
Mar 24
Here's Why BrainCool (NGM:BRAIN) Can Afford Some Debt
Nov 17We Think BrainCool (NGM:BRAIN) Has A Fair Chunk Of Debt
Jul 23Is BrainCool (NGM:BRAIN) A Risky Investment?
Mar 07How Much Did BrainCool's(NGM:BRAIN) Shareholders Earn From Share Price Movements Over The Last Five Years?
Jan 14Shareholder Returns
| BRAIN | SE Medical Equipment | SE Market | |
|---|---|---|---|
| 7D | -3.7% | -5.8% | -2.4% |
| 1Y | -68.4% | -7.8% | 10.9% |
Return vs Industry: BRAIN underperformed the Swedish Medical Equipment industry which returned -7.8% over the past year.
Return vs Market: BRAIN underperformed the Swedish Market which returned 10.9% over the past year.
Price Volatility
| BRAIN volatility | |
|---|---|
| BRAIN Average Weekly Movement | 6.0% |
| Medical Equipment Industry Average Movement | 7.3% |
| Market Average Movement | 5.5% |
| 10% most volatile stocks in SE Market | 11.2% |
| 10% least volatile stocks in SE Market | 3.3% |
Stable Share Price: BRAIN has not had significant price volatility in the past 3 months compared to the Swedish market.
Volatility Over Time: BRAIN's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2010 | 20 | Jon Berg | braincoolinc.com |
BrainCool AB (publ), a medical device company, together with its subsidiaries, engages in the development, marketing, and sale of medical cooling systems for the healthcare sector in Sweden. The company offers products for medical cooling treatments for a range of diseases, including stroke, sudden cardiac arrest, oral mucositis, and migraine. It provides BrainCool and RhinoChill systems that facilitates rapid medical cooling treatment in an emergency setting and ensures the continuum of care; Cooral system provides medical professionals an easy way to reduce the risk of oral mucositis; and IQool system offers an easy-to-use intuitive interface, informative graphics, and an automatic feedback loop allowing clinicians to manage their patient rather than a device.
BrainCool AB (publ) Fundamentals Summary
| BRAIN fundamental statistics | |
|---|---|
| Market cap | SEK 407.96m |
| Earnings (TTM) | -SEK 57.58m |
| Revenue (TTM) | SEK 40.67m |
9.8x
P/S Ratio-6.9x
P/E RatioIs BRAIN overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| BRAIN income statement (TTM) | |
|---|---|
| Revenue | SEK 40.67m |
| Cost of Revenue | SEK 29.14m |
| Gross Profit | SEK 11.54m |
| Other Expenses | SEK 69.12m |
| Earnings | -SEK 57.58m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Feb 10, 2025
| Earnings per share (EPS) | -0.23 |
| Gross Margin | 28.37% |
| Net Profit Margin | -141.57% |
| Debt/Equity Ratio | 0% |
How did BRAIN perform over the long term?
See historical performance and comparison